Literature DB >> 10979137

Effectiveness of treatment for sudden sensorineural hearing loss.

D Eisenman1, H A Arts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10979137     DOI： 10.1001/archotol.126.9.1161

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN： 0886-4470


× No keyword cloud information.
  12 in total

1.  [Intratympanic injection therapy for therapy refractory acute hearing loss: A safe option for secondary treatment].

Authors:  G Mühlmeier; S Maier; M Maier; H Maier
Journal:  HNO       Date:  2015-10       Impact factor: 1.284

2.  Hearing outcome does not depend on the interval of intratympanic steroid administration in idiopathic sudden sensorineural hearing loss.

Authors:  Hideaki Suzuki; Hiroki Koizumi; Jun-Ichi Ohkubo; Nobusuke Hohchi; Shoji Ikezaki; Takuro Kitamura
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-15       Impact factor: 2.503

3.  Prediction model for hearing outcome in patients with idiopathic sudden sensorineural hearing loss.

Authors:  Hideaki Suzuki; Takanori Mori; Koichi Hashida; Minori Shibata; Khac-Hung Nguyen; Tetsuro Wakasugi; Nobusuke Hohchi
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-11-03       Impact factor: 2.503

4.  The clinical analysis of bilateral successive sudden sensorineural hearing loss.

Authors:  Yaowen Wang; Litao Zhang; Jianhua Zhang; Xuqun Zhang; Weimin Zhang; Xing Chen; Shixiong Tang
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-04-06       Impact factor: 2.503

5.  Early hearing improvement predicts the prognosis of idiopathic sudden sensorineural hearing loss.

Authors:  Marie N Shimanuki; Seiichi Shinden; Naoki Oishi; Noriomi Suzuki; Kaho Iwabu; Tsubasa Kitama; Amina Kida; Koji Sakamoto; Kaoru Ogawa
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-01-02       Impact factor: 2.503

6.  Blocking the glucocorticoid receptor with RU-486 does not prevent glucocorticoid control of autoimmune mouse hearing loss.

Authors:  Dennis R Trune; J Beth Kempton
Journal:  Audiol Neurootol       Date:  2009-11-16       Impact factor: 1.854

7.  Use of intratympanic dexamethasone for the therapy of low frequency hearing loss.

Authors:  Necat Alatas
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-12-20       Impact factor: 2.503

8.  The role of allergy in the etiopathogenesis of idiopathic sudden sensorineural hearing loss.

Authors:  Erol Keleş; Emrah Sapmaz; Ahmet Gödekmerdan
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-09-25       Impact factor: 2.503

9.  Hyperbaric oxygen and steroid therapy for idiopathic sudden sensorineural hearing loss.

Authors:  Takeyuki Fujimura; Hideaki Suzuki; Teruo Shiomori; Tsuyoshi Udaka; Takanori Mori
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-03-06       Impact factor: 2.503

10.  Prognostic factors in sudden hearing loss.

Authors:  Raluca Enache; Codrut Sarafoleanu
Journal:  J Med Life       Date:  2008 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.